Merck KGaA And Sanofi-Aventis To Co-Develop Cancer Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
In a rare early-stage R&D collaboration, two Big Pharmas will evaluate novel combinations of signaling-pathway anticancers.